Weekly low-dose paclitaxel and carboplatin therapy in gynecological cancer patients with venous thrombosis

Anticancer Research

Volumn 28, Issue 6 B, 2008, Pages 3971-3975

  Tabata, Tsutomu ^a   Tanida, Kouji ^a   Umekawa, Takashi ^a   Shiozaki, Takaya ^a   Kondo, Eiji ^a   Nagao, Kenji ^a   Okugawa, Toshiaru ^a   Sagawa, Norimasa ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Gynecological cancer; Thrombosis

Indexed keywords

CARBOPLATIN; CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; WARFARIN;

ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SAFETY; ECHOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; VENOUS THROMBOSIS; WARFARIN;

EID: 58149160025     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Recio FO, Piver MS, Hempling RE and Driscoll DL: Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer 78: 2157-2163, 1996.
2. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, Van der Meer FJ and Rosendall FR: Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thrombo Haemost 4: 529-535, 2006.
3. Sorensen HT, Mellemkjaer L, Steffensen FH, Olsen JH and Nielsen GL: The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338: 1167-1173, 1998.
4. Tateo S, Mereu L, Salamano S, Klersy C, Barone M, Spyropoulos AC and Piovella F: Ovarian cancer and venous thrombolic risk. Gynecol Oncol 99: 119-125, 2005.
5. Thompson ME and Highley MS: Interaction between paclitaxel and warfarin. Ann Oncol 14: 500, 2003.
6. Le AT, Hasson NK and Lum BL: Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy. Ann Pharmacother 31: 1006-1008, 1997.
7. Havrilesky LJ, Alvarez AA, Sayer RA, Lancaster JM, Soper JT, Berchuck A, Clarke-Pearson DL, Rodriguez GC and Carney ME: Weekly low-dose carboplatin and paclitaxel in the treatment of recurrent ovarian and peritoneal cancer. Gynecol Oncol 88: 51-57, 2003.
8. Wu CH, Yang CH, Lee JN, Hsu SC and Tsai EM: Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects. Int J Gynecol Cancer 11: 295-299, 2001.
9. Kikuchi A, Sakamoto H and Yamamoto T: Weekly carboplatin and paclitaxel is safe, active, and well tolerated in recurrent ovarian cancer cases of Japanese women previously treated with cisplatin-containing multidrug chemotherapy. Int J Gynecol Cancer 15: 45-49, 2005.
10. Watanabe Y, Nakai H, Ueda H and Hoshiai H: Evaluation of weekly low-dose paclitaxel and carboplatin treatment for patients with platinum-sensitive relapsed ovarian cancer. Gynecol Oncol 96: 323-329, 2005.
11. Sevelda P, Mayerhofer K, Obermair A, Stolzlechner J and Kurz C: Thrombosis with paclitaxel. Lancet 343: 727, 1994.
12. Chan AT, Yeo W, Leung WT and Johnson PJ: Thromboembolic events with paclitaxel. Clin Oncol 8: 133, 1996.
13. Levine MN: Prevention of thrombotic disorders in cancer patients undergoing chemotherapy. Thromb Haemost 78: 133-136, 1997.
14. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Huh WK, Jaggernauth W, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR, Morgan M, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Secord AA, Small W Jr and Teng N: NCCN Clinical Practice Guidelines in Oncology™ Uterine Neoplasms v.1 2008 (http://www.nccn.org/shy; professionals/ physician_gls/PDF/uterine.pdf) 2008.
15. Creasman WT, Odicino F, Maisonnecuve P, Beller U, Benedet JL, Heintz AP, Ngan HY and Pecorelli S: Carcinoma of the corpus uteri. Int J Gynecol Obstet 83: 79-118, 2003.
16. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S and Kudo R: Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108: 226-233, 2008.
17. Takeshima N, Umayahara K, Fujiwara K, Hirai Y, Takizawa K and Hasumi K: Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer. Gynecol Oncol 102: 214-217, 2006.
18. Sovak MA, Hensley ML, Dupont J, Ishill N, Alektiar KM, Abu-Rustum N, Barakat R, Chi DS, Sabbatini P, Spriggs DR and Aghajanian C: Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study. Gynecol Oncol 103: 451-457, 2006.
19. Hirai M, Hirono M, Oosaki T, Hayashi Y, Yoshihara T and Itami M: Adjuvant chemotherapy in stage I uterine endometrial carcinoma. Int J Gynecol Obstet 78: 37-44, 2002.
20. Otsuka I, Kubota and Aso T: Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy. Br J Cancer 87: 377-380, 2002.
21. Aoki Y, Watanabe M, Amikura T, Obata H, Sekine M, Yahata T, Fujita K and Tanaka K: Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer. Gynecol Oncol 94: 333-339, 2004.
22. Kodama J, Seki N, Ojima Y, Nakamura K, Hongo A and Hiramatsu Y: Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus. Eur J Obstet Gynecol Reprod Biol 131: 76-80, 2007.
23. Chan AT, Yeo W, Leung WT and Johnson PJ: Thromboembolic events with paclitaxel. Clin Oncol 8: 133, 1996.